Javascript must be enabled to continue!
Ameliorative effect of Cassia singueana extract against acute ketamine induced cognitive impairment in murine models of schizophrenia
View through CrossRef
Introduction: In the quest for search of novel pharmacotherapy from medicinal plants for psychiatric disorders, it has progressed appreciably for the past few decades and their therapeutic potential has been evaluated in a variety of murine models. Cassia singueana Del. is a commonly used medicinal plant in Nigeria for management of insanity and as lactation enhancer. Aim: The main aim of this study was to evaluate the cognitive potential of Cassia singueana extract against ketamine-induced cognitive impairment in mice. Methods: The phytochemicals and elemental minerals present in the extract were determined using standard protocol and antioxidant potential of the extract was evaluated using TBA-TCAA protocols, while its oral median lethal dose (LD50) in mice was estimated by OECD protocol. The effect of Cassia singueana extract (100, 200 and 400 mg/kg) on neurobehavioral deficit was evaluated in mice using behavioural paradigms: Y- maze, novel object recognition, forced swim test, open field test and catalepsy test. Results: The phytochemical constituents of Cassia singueana were alkaloids, cardiac glycosides, tannins, flavonoids, saponins, steroids and triterpenes. The extract also significantly decreased the level of MDA and increased the level of SOD and GSH. Oral LD50 was estimated to be >5000 mg/kg. Cassia singueana extract significantly (P< 0.05) increased the exploration time of novel object and percentage recognition index during the retention phase of the NORT. In Y-maze test, the extract significantly (p<0.05) increased the number of actual alternation and the percentage spontaneous alternation. It also significantly (p<0.05) decreased the duration of immobility in forced swim test. The extract also significantly (p<0.05) increased the number of central and peripheral square cross in open field. The extract also did not prolong the duration of catalepsy induced by haloperidol in glass bar test. Conclusion: Cassia singueana extract contained phytochemicals that could ameliorate cognitive impairment and negative symptoms of schizophrenics.
Title: Ameliorative effect of Cassia singueana extract against acute ketamine induced cognitive impairment in murine models of schizophrenia
Description:
Introduction: In the quest for search of novel pharmacotherapy from medicinal plants for psychiatric disorders, it has progressed appreciably for the past few decades and their therapeutic potential has been evaluated in a variety of murine models.
Cassia singueana Del.
is a commonly used medicinal plant in Nigeria for management of insanity and as lactation enhancer.
Aim: The main aim of this study was to evaluate the cognitive potential of Cassia singueana extract against ketamine-induced cognitive impairment in mice.
Methods: The phytochemicals and elemental minerals present in the extract were determined using standard protocol and antioxidant potential of the extract was evaluated using TBA-TCAA protocols, while its oral median lethal dose (LD50) in mice was estimated by OECD protocol.
The effect of Cassia singueana extract (100, 200 and 400 mg/kg) on neurobehavioral deficit was evaluated in mice using behavioural paradigms: Y- maze, novel object recognition, forced swim test, open field test and catalepsy test.
Results: The phytochemical constituents of Cassia singueana were alkaloids, cardiac glycosides, tannins, flavonoids, saponins, steroids and triterpenes.
The extract also significantly decreased the level of MDA and increased the level of SOD and GSH.
Oral LD50 was estimated to be >5000 mg/kg.
Cassia singueana extract significantly (P< 0.
05) increased the exploration time of novel object and percentage recognition index during the retention phase of the NORT.
In Y-maze test, the extract significantly (p<0.
05) increased the number of actual alternation and the percentage spontaneous alternation.
It also significantly (p<0.
05) decreased the duration of immobility in forced swim test.
The extract also significantly (p<0.
05) increased the number of central and peripheral square cross in open field.
The extract also did not prolong the duration of catalepsy induced by haloperidol in glass bar test.
Conclusion: Cassia singueana extract contained phytochemicals that could ameliorate cognitive impairment and negative symptoms of schizophrenics.
Related Results
Vegetable Tannins as Chrome-Free Leather Tanning
Vegetable Tannins as Chrome-Free Leather Tanning
The purpose of this study is to replace chrome tannins with ecofriendly vegetable tannins as an alternative solution to prevent the public health and the environmental pollution. V...
Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature
Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature
Serotonin (5-HT) syndrome (SS) consists of changes in mental status as well as autonomic and neuromuscular changes. Though not well understood, serotonergic pathways have been impl...
Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats
Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats
Abstract
Schizophrenia is a neuropsychiatric disorder with limited treatment options that have unwanted side effects. Clozapine, an atypical antipsychotic, has been used ...
Analgesic Mechanisms of Ketamine in the Presence and Absence of Peripheral Inflammation
Analgesic Mechanisms of Ketamine in the Presence and Absence of Peripheral Inflammation
Background
The studies on the mechanisms of ketamine antinociception have led to conflicting results. In this study, the authors investigated the contribution of supras...
Newer therapies and surgical management of ketamine-induced uropathy: A review
Newer therapies and surgical management of ketamine-induced uropathy: A review
Background and Aims: Ketamine use as a recreational drug is becoming more popular nowadays. Ketamine-induced uropathy (KIU) is a late finding observed with long-term use of ketamin...
Xylazine-Ketamine Outperforms Diazepam-Ketamine in Rabbit Anesthesia
Xylazine-Ketamine Outperforms Diazepam-Ketamine in Rabbit Anesthesia
Background: Limited research on the effects of ketamine combinations on rabbit anesthesia underscores the need for safe and effective injectable methods. Specific Background: This ...
Basic Science (28)
Basic Science (28)
Analgesic mechanisms of ketamine in the presence and absence of peripheral. (Sapporo Medical University School of Medicine, Sapporo, Japan) Anesthesiology 2000;93:520–528.In this s...
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understanding the etiology of depression. Ketamine was originally used as an anesthetic dru...

